ASTMH 2010

[November 3-7, 2010]
Atlanta, USA

The Drugs for Neglected Diseases initiative (DNDi) will participate in several activities at ASTMH 2010, including a joint symposium with Central Drug Research Institute (CDRI)on Visheral Leishmaniasis (VL) in the Indian Continent, a second symposium on VL in East Africa, a satellite symposium on Challenges and Successes of the FACT Project through Innovative Partnerships for the development of Artesunate Combination Therapies for Malaria, as well as several oral presentations.


•    Friday, November 05, 2010 (1:30pm—3:15pm)

Title: Current Challenges and Opportunities in managing Visceral Leishmaniasis in the Indian subcontinent

Jointly organized by Drugs for Neglected Diseases initiative (DNDi) & Central Drug Research Institute (CDRI)

Chair: Prof. Kwang Poo Chang, Rosalind Franklin University of Medicine and Science, USA
Co-chair: Prof. Farrokh Modabber; Drugs for Neglected Diseases initiative (DNDi), Switzerland

puce Profs Kwang Poo Chang & Farrokh Modabber: Opening Remarks
puce Prof. Shyam Sundar (Banaras Hindu University, India): General Introduction and Current Clinical Management of VL in the Indian subcontinent
puce Prof Farrokh Modabber (DNDi, Switzerland): Potential new treatment options for VL: Combination therapy with liposomal amphotericin B, miltefosine and paromomycin
puce Dr. Larry Ming C. Chow (Hong Kong Polytechnic University Hong Kong): Strategies of reversing drug-resistance by using flavinoid dimmers
puce Prof. K.P. Chang (Chicago Medical School/RFUMS, USA): Therapeutic/prophylactic strategies with minimal risks of eliciting drug-resistance – Photomedicine
puce Dr. Neeloo Singh (Central Drug Research Institute, India): Analysis of drug resistance in clinical isolates
puce Panel members: Profs Jorger Alvar, Piero Olliaro: Panel discussion and question and answers

•   Saturday, November 06, 2010 (1:30pm—3:15pm)

Title: VL in East Africa- Current Needs and Latest Clinical Developments

Jointly organized by Drugs for Neglected Diseases initiative (DNDi) &  Leishmania East Africa Platform (LEAP)

Chair: Prof. Ahmed El Hassan, University of Khartoum, Sudan
Co-chair: Prof. Joseph Olobo, Makerere University, Kampala, Uganda

puce Dr. Monique Wasunna (Kenya Medical Research Institute, KEMRI): Leishmania East Africa Platform: a model for a clinical research platform in Africa
puce Dr. Manica Balasegaram (DNDi): Economic analysis of visceral leishmaniasis control in Sudan
puce Prof. Asrat Hailu (Addis Ababa University, Ethiopia): Ambisome: The experience in East Africa 
puce Dr. Ahmed Mudawi Musa (University of Khartoum, Sudan): A multicentre comparative trial of efficacy and safety of sodium stibogluconate (SSG), paromomycin (PM) and the combination of SSG and pM as first-line treatment for visceral leishmaniasis in East Africa

Satellite Symposium

•    Friday, November 05, 2010 (7:15pm—9:00pm)

Title: Challenges and Successes of the FACT Project through Innovative Partnerships for the Development of Artesunate Combination Therapies for Malaria

Chair: Chair: Prof. Nicholas White (Wellcome Trust Mahidol University, Bangkok, Thailand)
Co-chair: Dr. Piero Olliaro (WHO/TDR, Geneva, Switzerland)

puce Dr. Jean-René Kiechel (DNDi): Partnerships: The Way to Successful Antimalarial Development
puce Dr. Francois Bompart (sanofi-aventis, Paris, France): Public-Private Partnerships for ACT Development and Field Implementation
puce Dr. Ana Carolina Santelli (Brasilian Malaria Control Programme, Brazil): Implementation of ASMQ – Brazilian experience
puce Dr. Neena Valecha (National Institute of Malaria Research, New Delhi, India): Partnership in India and Beyond
puce Dr. Bernard Pécoul (DNDi): What Next? The Future of Partnerships


DNDi’s booth is #408. Please visit our team there to receive information about DNDi’s activities.